| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Pietro Zara, Alessandro Dinoto, Sara Carta, Valentina Floris, Davide Turilli, Adrian Budhram, Sergio Ferrari, Stefania Milia, Paolo Solla, Sara Mariotto, Eoin P Flanagan, A Sebastian Lopez Chiriboga, Elia Sech. Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review. European journal of neurology. 2023-07-11. PMID:37433584. |
while multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein-igg associated disease (mogad) represent major and well-defined differential diagnoses, non-demyelinating nmosd mimics remain poorly characterized. |
2023-07-11 |
2023-08-14 |
Not clear |
| Kimystian L Harrison, Cristina Gaudioso, Victoria A Levasseur, S Richard Dunham, Natalie Schanzer, Connor Keuchel, Amber Salter, Manu S Goyal, Soe Ma. Central Vein Sign in Pediatric Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Pediatric neurology. vol 146. 2023-07-05. PMID:37406422. |
central vein sign in pediatric multiple sclerosis and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-07-05 |
2023-08-14 |
Not clear |
| Kimystian L Harrison, Cristina Gaudioso, Victoria A Levasseur, S Richard Dunham, Natalie Schanzer, Connor Keuchel, Amber Salter, Manu S Goyal, Soe Ma. Central Vein Sign in Pediatric Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Pediatric neurology. vol 146. 2023-07-05. PMID:37406422. |
the central vein sign (cvs) on brain magnetic resonance imaging (mri) is a promising diagnostic marker for distinguishing adult multiple sclerosis (ms) from other demyelinating conditions, but its prevalence is not well-established in pediatric-onset multiple sclerosis (poms) versus myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2023-07-05 |
2023-08-14 |
Not clear |
| Milton Guilherme Forestieri Fernandes, Abdulshakour Mohammadnia, Florian Pernin, Laura Eleonora Schmitz-Gielsdorf, Caroline Hodgins, Qiao-Ling Cui, Moein Yaqubi, Manon Blain, Jeffery Hall, Roy Dudley, Myriam Srour, Stephanie E J Zandee, Wendy Klement, Alexandre Prat, Jo Anne Stratton, Moses Rodriguez, Tanja Kuhlmann, Wayne Moore, Timothy E Kennedy, Jack P Ante. Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis. Acta neuropathologica communications. vol 11. issue 1. 2023-07-05. PMID:37408029. |
oligodendrocyte (ol) injury and loss are central features of evolving lesions in multiple sclerosis. |
2023-07-05 |
2023-08-14 |
human |
| Qiao Xu, Xixi Yang, Zhandong Qiu, Dawei Li, Hongxing Wang, Hong Ye, Lidong Jiao, Jing Zhang, Li Di, Peng Lei, Huiqing Dong, Zheng Li. Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS. Multiple sclerosis and related disorders. vol 77. 2023-07-04. PMID:37402345. |
clinical features of mogad with brainstem involvement in the initial attack versus nmosd and ms. to assess the characteristics of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) with brainstem involvement in the first event (bsife) and make comparisons with aquaporin-4-igg seropositive neuromyelitis optica spectrum disorder (aqp4-igg-nmosd) and multiple sclerosis (ms). |
2023-07-04 |
2023-08-14 |
Not clear |
| Maryam Zoghi, Shapour Jaberzade. A step toward restoring hand functions in patients with multiple sclerosis-a study protocol. Frontiers in rehabilitation sciences. vol 4. 2023-06-30. PMID:37387732. |
multiple sclerosis (ms) is a chronic autoimmune disease characterized by inflammation, demyelination of axons, and oligodendrocyte loss in the central nervous system. |
2023-06-30 |
2023-08-14 |
human |
| Jessica Frau, Giancarlo Coghe, Lorena Lorefice, Giuseppe Fenu, Eleonora Cocc. The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases. Life (Basel, Switzerland). vol 13. issue 6. 2023-06-28. PMID:37374092. |
multiple sclerosis (ms), neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are inflammatory diseases of the central nervous system (cns) with a multifactorial aetiology. |
2023-06-28 |
2023-08-14 |
human |
| Edgar Carnero Contentti, Darin T Okuda, Juan I Rojas, Claudia Chien, Friedemman Paul, Ricardo Alons. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2023-06-15. PMID:37322542. |
differentiating multiple sclerosis (ms) from other relapsing inflammatory autoimmune diseases of the central nervous system such as neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is crucial in clinical practice. |
2023-06-15 |
2023-08-14 |
Not clear |
| Marc Dinkin, Swetha Sath. Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19. Seminars in neurology. 2023-06-13. PMID:37311536. |
optic neuritis has frequently been reported, sometimes along with acute disseminated encephalomyelopathy, often in association with either myelin oligodendrocyte glycoprotein antibodies (mog-igg) or less commonly aquaporin-4 seropositivity or in newly diagnosed multiple sclerosis. |
2023-06-13 |
2023-08-14 |
Not clear |
| Hans Lassman. Top ten discoveries of the year: Neuroinflammation. Free neuropathology. vol 1. 2023-06-07. PMID:37283667. |
they include topics related to new mechanisms of inflammation and immune mediated neurodegeneration, which are relevant for multiple sclerosis (publications 1 to 4) and discuss the role of specific autoantibodies against myelin oligodendrocyte glycoprotein or aquaporin 4 in neuromyelitis optica spectrum disorders (publications 5 and 6). |
2023-06-07 |
2023-08-14 |
Not clear |
| Assia Tiane, Melissa Schepers, Rick A Reijnders, Lieve van Veggel, Sarah Chenine, Ben Rombaut, Emma Dempster, Catherine Verfaillie, Kobi Wasner, Anne Grünewald, Jos Prickaerts, Ehsan Pishva, Niels Hellings, Daniel van den Hove, Tim Vanmierl. From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta neuropathologica. 2023-06-07. PMID:37286732. |
in the progressive phase of multiple sclerosis (ms), the hampered differentiation capacity of oligodendrocyte precursor cells (opcs) eventually results in remyelination failure. |
2023-06-07 |
2023-08-14 |
Not clear |
| Yu Xie, Chaolei Jin, Hongzhen Sang, Wenhua Liu, Junpeng Wan. Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway. Inflammation. 2023-05-25. PMID:37227550. |
multiple sclerosis (ms), a t-cell-mediated autoimmune disease that affects the central nervous system (cns), is characterized by white matter demyelination, axon destruction, and oligodendrocyte degeneration. |
2023-05-25 |
2023-08-14 |
mouse |
| Vyanka Redenbaugh, Nicholas H Chia, Laura Cacciaguerra, Jennifer A McCombe, Jan-Mendelt Tillema, John J Chen, A Sebastian Lopez Chiriboga, Elia Sechi, Yael Hacohen, Sean J Pittock, Eoin P Flanaga. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-05-23. PMID:37218499. |
magnetic resonance imaging (mri) t2-lesions resolve more often in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) than aquaporin-4 igg-positive neuromyelitis optica spectrum disorder (aqp4 + nmosd) and multiple sclerosis (ms) in adults but few studies analyzed children. |
2023-05-23 |
2023-08-14 |
Not clear |
| Yanan Chen, Songhua Quan, Vaibhav Patil, Rejani B Kunjamma, Haley M Tokars, Eric D Leisten, Godwin Joy, Samantha Wills, Jonah R Chan, Yvette C Wong, Brian Popk. Insights into the mechanism of oligodendrocyte protection and remyelination enhancement by the integrated stress response. Glia. 2023-05-19. PMID:37203250. |
ifn-γ, which is a critical inflammatory cytokine in multiple sclerosis (ms), inhibits oligodendrocyte precursor cell (opc) differentiation in culture and triggers a mild isr. |
2023-05-19 |
2023-08-14 |
mouse |
| Brian Florenzo, J Nicholas Brento. Socioeconomic, Clinical, and Laboratory Parameters Differentiating Pediatric Patients With MOG Antibody-Associated Disease and Multiple Sclerosis. Journal of child neurology. 2023-05-01. PMID:37122175. |
studies indicate differences in the clinical phenotypes and neuroimaging of children with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) compared to multiple sclerosis; however, there are limited data assessing the socioeconomic and paraclinical differences between these distinct disorders. |
2023-05-01 |
2023-08-14 |
human |
| Kathryn B Holroyd, Sarah E Conwa. Central Nervous System Neuroimmunologic Complications of COVID-19. Seminars in neurology. 2023-04-20. PMID:37080234. |
autoimmune disorders of the central nervous system following covid-19 infection include multiple sclerosis (ms), neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune encephalitis, acute disseminated encephalomyelitis, and other less common neuroimmunologic disorders. |
2023-04-20 |
2023-08-14 |
Not clear |
| Em P Harrington, Riley B Catenacci, Matthew D Smith, Dongeun Heo, Cecilia E Miller, Keya R Meyers, Jenna Glatzer, Dwight E Bergles, Peter A Calabres. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis. eLife. vol 12. 2023-04-14. PMID:37057892. |
mhc class i and mhc class ii reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis. |
2023-04-14 |
2023-08-14 |
mouse |
| Tianrong Yeo, Rachel Wan En Siew, Muhammad Yaaseen Gulam, Janis Siew Noi Tye, Amelia Yun Yi Aw, Thanushiree Sivalingam, Xuejuan Peng, Kok Pin Yong, Seyed Ehsan Saffari, Yinxia Chao, Kevin Ta. COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore. Journal of neurology. 2023-04-07. PMID:37027019. |
herein, we investigate the incidence and risk factors for covid-19 infection in vaccinated adult patients with multiple sclerosis (ms), aquaporin-4-antibody neuromyelitis optica spectrum disorder (aqp4-ab nmosd), and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad) during the omicron subvariant ba.1/2 wave in singapore. |
2023-04-07 |
2023-08-14 |
Not clear |
| Matthew R Brier, Biao Xiang, John R Ciotti, Salim Chahin, Gregory F Wu, Robert T Naismith, Dmitriy Yablonskiy, Anne H Cros. Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD. Multiple sclerosis and related disorders. vol 73. 2023-04-02. PMID:37004272. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a distinct central nervous system (cns) disorder that shares features with multiple sclerosis (ms) and may be misdiagnosed as ms. mogad and ms share a frequently relapsing clinical course and lesions with inflammatory demyelinating pathology. |
2023-04-02 |
2023-08-14 |
Not clear |
| Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, Michael Waltz, Rachel Codden, Leslie Benson, Mark Gorman, Manu Goyal, Lauren Krupp, Tim Lotze, Soe Mar, Jayne Ness, Mary Rensel, Shelly Roalstad, Moses Rodriguez, John Rose, Nikita Shukla, Emmanuelle Waubant, Yolanda Wheeler, T Charles Casper, Tanuja Chitni. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-03-24. PMID:36960480. |
pediatric patients with multiple sclerosis (poms) and related disorders, clinically isolated syndrome (cis), myelin oligodendrocyte glycoprotein antibody disorder (mogad), and neuromyelitis optica spectrum disorder (nmosd), are commonly treated with immunosuppressants. |
2023-03-24 |
2023-08-14 |
Not clear |